|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
TRIMETHOPRIM AND SULFAMETHOXAZOLE
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Shigellosis |
|
Bronchitis, chronic, acute exacerbation |
|
Diarrhea, infectious |
|
Infection, ear, middle |
|
Infection, lower respiratory tract |
|
Infection, urinary tract |
|
Pneumonia, pneumocystis carinii |
| |
|
|
SIDE EFFECTS:
|
|
Hypersensitivity |
|
photosensitivity |
|
Blood dyscrasias |
|
cholestatic hepatitis |
|
pancreatitis |
|
Stevens-Johnson syndrome |
|
toxic epidermal necrolysis |
|
Aseptic meningitis |
|
central nervous system (CNS) toxicity |
|
Clostridium difficile colitis |
|
crystalluria or hematuria |
|
goiter or thyroid function disturbance |
|
interstitial nephritis or tubular necrosis |
|
methemoglobinemia |
|
rhabdomyolysis |
|
thrombophlebitis |
|
CNS effects |
|
gastrointestinal disturbances |
|
glossitis or stomatitis |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Blood dyscrasias |
|
>> Megaloblastic anemia due to folate deficiency |
|
>> Glucose-6-phosphate dehydrogenase deficiency |
|
>> Hepatic function impairment |
|
>> Porphyria |
|
>> Renal function impairment |
|
|
ADULT DOSE:
|
|
Antibacterial (systemic)-
Oral, 800 mg of sulfamethoxazole and 160 mg of trimethoprim every twelve hours.
Antiprotozoal-
Pneumocystis carinii pneumonia -
Treatment:
Oral, 18.75 to 25 mg of sulfamethoxazole and 3.75 to 5 mg of trimethoprim per kg of body weight every six hours for fourteen to twenty-one days .
Prophylaxis :
Oral, 800 mg of sulfamethoxazole and 160 mg of trimethoprim once a day.
Acceptable alternative dosing schedules include-
Oral, 800 mg of sulfamethoxazole and 160 mg of trimethoprim three times a week (e.g., Monday, Wednesday, Friday) .
Oral, 400 mg of sulfamethoxazole and 80 mg of trimethoprim once a day .
[Toxoplasmosis (prophylaxis)] -
Oral, 800 mg of sulfamethoxazole and 160 mg of trimethoprim once a day.
Acceptable alternative dosing schedules include:
Oral, 800 mg of sulfamethoxazole and 160 mg of trimethoprim three times a week (e.g., Monday, Wednesday, Friday) .
Oral, 400 mg of sulfamethoxazole and 80 mg of trimethoprim once a day.
[ HIV-related infection in Africa (prophylaxis)] -
Oral, 800 mg of sulfamethoxazole and 160 mg of trimethoprim once a day . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Antibacterial (systemic)-
Infants up to 2 months of age-
Use is not recommended since sulfonamides may cause kernicterus in neonates.
Infants 2 months of age and over-
Infants and children up to 40 kg of body weight-Oral, 20 to 30 mg of sulfamethoxazole and 4 to 6 mg of trimethoprim per kg of body weight every twelve hours.
Children 40 kg of body weight and over-See Usual adult and adolescent dose.
Antiprotozoal-
Pneumocystis carinii pneumonia (PCP)-
Treatment:
Oral, 18.75 to 25 mg of sulfamethoxazole and 3.75 to 5 mg of trimethoprim per kg of body weight every six hours for fourteen to twenty-one days.
Prophylaxis :
Children 4 weeks of age and over-
Oral, 375 mg of sulfamethoxazole per square meter and 75 mg of trimethoprim per square meter of body surface two times a day, three times a week on consecutive days (e.g., Monday, Tuesday, Wednesday).
Acceptable alternative dosing schedules include -
Oral, 750 mg of sulfamethoxazole per square meter and 150 mg of trimethoprim per square meter of body surface as a single daily dose three times a week on consecutive days (e.g., Monday, Tuesday, Wednesday).
Oral, 375 mg of sulfamethoxazole per square meter and 75 mg of trimethoprim per square meter of body surface two times a day seven days a week.
Oral, 375 mg of sulfamethoxazole per square meter and 75 mg of trimethoprim per square meter of body surface two times a day, three times a week on alternate days (e.g., Monday, Wednesday, Friday).
Note:
PCP prophylaxis is recommended for all infants born to HIV-infected mothers starting at 4 weeks of age, regardless of their CD4 lymphocyte counts. However, if the infant is receiving zidovudine during the first 6 weeks of life for the prevention of perinatal HIV transmission, sulfamethoxazole and trimethoprim combination prophylaxis should be delayed until zidovudine is discontinued at 6 weeks of age, to reduce the chance of anemia that may occur if these two medications are given concurrently.
[Toxoplasmosis (prophylaxis)] -
Oral, 375 mg of sulfamethoxazole per square meter and 75 mg of trimethoprim per square meter of body surface two times a day, three times a week on consecutive days (e.g., Monday, Tuesday, Wednesday).
Acceptable alternative dosing schedules include:
Oral, 750 mg of sulfamethoxazole per square meter and 150 mg of trimethoprim per square meter of body surface as a single daily dose three times a week on consecutive days (e.g., Monday, Tuesday, Wednesday).
Oral, 375 mg of sulfamethoxazole per square meter and 75 mg of trimethoprim per square meter of body surface two times a day seven days a week.
Oral, 375 mg of sulfamethoxazole per square meter and 75 mg of trimethoprim per square meter of body surface two times a day, three times a week on alternate days (e.g., Monday, Wednesday, Friday).
[HIV-related infection in Africa (prophylaxis)] -
Studies have not been performed in children . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|